Last edition
News about "precision medicines"
US-based biopharmaceutical company Precigen has received approval from the Food and Drug Administration (FDA) for its immunotherapy PAPZIMEOS (zopapogene imadenovec-drba) for the treatment of adults with recurrent respiratory papillomatosis (RRP).
Precision Medicines | 16/08/2025 | By Dineshwori | 197
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members